Members of the Acute Dialysis Quality Initiative (ADQI) participated in a 3-day conference in Vicenza in May 2007 to evaluate the available literature on this topic and draft consensus recommendations for research studies in this area. This report summarizes the available evidence and describes the key questions that will need to be addressed with the goal of standardizing the care of patients with cardiac surgery-associated acute kidney injury (CSA-AKI) and improving outcomes.
RosnerM., OkusaM.. Acute kidney injury associated with cardiac surgery.Clin J Am Soc Nephrol2006; 1: 19–32.
3.
IhleB.. Acute renal dysfunction after cardiac surgery: Still a big problem!Heart, Lung, and Circulation2007; 16(Suppl 3): S39–44.
4.
BoldtJ., BrennerT., LehmannA., LangJ., KumleB., WerlingC.. Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: Comparison of a new starch preparation with gelatin.Intensive Care Med2003; 29: 763–9.
5.
WinkelmayerW., GlynnR., LevinR., AvornJ.. Hydroxyethyl starch and change in renal function in patients undergoing coronary artery bypass graft surgery.Kidney Int2003; 64: 1046–9.
6.
FinferS., BellomoR., BoyceN., FrenchJ., MyburghJ., NortonR.. SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit.N Engl J Med2004; 350: 2247–56.
7.
BoldtJ., BroschC., DuckeM., PapsdorfM.. Influence of volume therapy with a modern hydroxyethylstarch preparation on kidney function in cardiac surgery patients with compromised renal function: A comparison with human albumin.Crit Care Med2007; 35: 2740–6.
8.
RobertsI., AldersonP., BunnF., ChinnockP., KerK., SchierhoutG.. Colloids versus crystalloids for fluid resuscitation in critically ill patientsCochrane Database of Systematic Reviews2007 Issue 2.
9.
MorimatsuH., UchinoS., ChungJ., BellomoR., RamanJ., BuxtonB.. Norepinephrine for hypotensive vasodilatation after cardiac surgery: impact on renal function.Intensive Care Med2003; 29: 1106–12.
10.
LeeR., GiantomassoD., BellomoR.. Vasoactive drugs and the kidney.Best Pract Res Clin Anaesthesiol2004; 18: 53–74.
11.
GilliesM., BellomoR., DoolanL., BuxtonB.. Bench-to-bedside review: inotropic drug therapy after adult cardiac surgery-a systematic literature review.Crit Care2005; 9: 266–79.
12.
CostaP., OttinoG.M., MataniA.. Low-dose dopamine during cardiopulmonary bypass in patients with renal dysfunction.J Cardiothorac Anesth1990; 4: 469–73.
13.
DentonM.D., ChertowG.M., BradyH.R.. Renal dose dopamine for the treatment of acute renal failure: Scientific rationale, experimental studies, and clinical trials.Kidney Int1996; 49: 4–14.
14.
DogrellS.A.. The therapeutic potential of dopamine modulators on the cardiovascular and renal systems.Expert Opin Investig Drugs2002; 11: 631–44.
15.
BellomoR., ChapmanM., FinferS., HicklingK., MyburghJ.. Low dose-dopamine in patients with early renal dysfunction: A placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group.Lancet2000; 356: 2139–43.
16.
KellumJ., DeckerJ.. Use of dopamine in acute renal failure: A meta-analysis.Crit Care Med2001; 29: 1526–31.
17.
LauschkeA., TeichgraberU.K.M., FreiU., EckardtK-U. Low-dose dopamine worsens renal perfusion in patients with acute renal failure.Kidney Int2006; 69: 1669–74.
18.
FriedrichJ.O., AdhikariN., HerridgeM.S., BeyenneJ.. Metaanalysis: Low-dose dopamine increases urine output but does not prevent renal dysfunction or death.Ann Intern Med2005; 142: 510–24.
19.
HalpennyM., LakshmiS., O'DonnellA., O'Callaghan-EnrightS., ShortenG.D.. Fenoldopam: Renal and splanchnic effects in patients undergoing coronary artery bypass grafting.Anaesthesia2001; 56: 953–60.
GarwoodD., SwamidossC.P., DavisE.A., SamsonL., HinesR.L.. A case series of low-dose fenoldopam in seventy cardiac surgery patients at increased risk of renal dysfunction.J Cardiothorac Vasc Anesth2003; 17: 17–21.
22.
CaimmiP.P., PaganiL., MicalizziE., FiumeG., GuaniS., BernardiM.. Fenoldopam for renal protection in patients undergoing cardiopulmonary bypass.J Cardiothorac Vasc Anesth2003; 17: 491–4.
23.
TumlinJ.A., FinkelK.W., MurrayP.T., SamuelsJ., CotsonisG., ShawA.D.. Fenoldopam mesylate in early acute tubular necrosis: a randomized, double-blind, placebo-controlled clinical trial.Am J Kidney Dis2005; 46: 26–34.
24.
RanucciM., SoroG., BarzaghiN., LocatelliA., GiordanoG., VavassoriA., ManzatoA., MelchiorriC., BoveT., JulianoG., UslenghiM.F.. Fenoldopam prophylaxis of postoperative acute renal failure in high-risk cardiac surgery patients.Ann Thorac Surg2004; 78: 1332–7.
25.
BoveT., LandoniG., CalabroM., AlettiG., MarinoG., CerchieriniE., CrescenziG., ZangrilloA.. Renoprotective action of fenoldopam in high-risk patients undergoing cardiac surgery: a prospective, double-blind randomized clinical trial.Circulation2005; 3230–5.
26.
RahmanS.N., KimG.E., MathewA.S., GoldbergC.A., AllgrenR., SchrierR.W., CongerJ.D.. Effects of atrial natriuretic peptide in clinical acute renal failure.Kidney Int1994; 45: 1731–8.
27.
ValssonF., RickstenS.E., HednerT.. Lundin S. Effects of atrial natriuretic peptide on acute renal impairment in patients with heart failure after cardiac surgery.Intensive Care Med1996; 22: 230–6.
28.
SezaiA., ShioniM., OrineY.. Low-dose continuous infusion of human atrial natriuretic peptide during and after cardiac surgery.Ann Thorac Surg2000; 69: 732–8.
29.
SezaiA., HataM., WakuiS.. Efficacy of low-dose continuous infusion of human atrial natriuretic peptide (hANP) during cardiac surgery. Possibility of postoperative left ventricular remodeling effect.Circ J2006; 70: 1426–31.
30.
SezaiA., HataM., WakuiS.. Efficacy of continuous low-dose hANP administration in patients undergoing emergent coronary artery bypass grafting for acute coronary syndrome.Circ J2007; 71: 1401–7.
BeaverT.M., WintersteinA.G., ShusterJ.J.. Effectiveness of nesiritide on dialysis or all-cause mortality in patients undergoing cardiothoracic surgery.Clin Cardiol2006; 29: 18–24.
36.
MentzerR.M., Oz Mc SladenR.N.. Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery. The NAPA Trial.J Am Coll Cardiol2007; 49: 716–26.
37.
LombardiR., FerrieroA., ServettoC.. Renal function afater cardiac surgery: adverse effect of furosemide.Ren Fail2003; 25: 775–86.
38.
SirivellaA., GielchinskyI., ParsonnetV.. Mannitol, furosemide, and dopamine infusion in postoperative renal failure complicating cardiac surgery.Ann Thorac Surg2000; 69: 501–6.
39.
KleinknechtD., GanevalD., Gonzales-DuqueL.A., FermanianJ.. Furosemide in acute oliguric renal failure. A controlled trial.Nephron1976; 17: 51–8.
40.
NuutinenL., HollmenA.. The effect of prophylactic use of furosemide on renal function during open heart surgery.Ann Chir Gynaecol1967; 65: 258–66.
41.
BrownC.B., OggC.S., CameronJ.S.. High dose furosemide in acute renal failure: a controlled trial.Clin Nephrol1981; 15: 90–6.
42.
ShillidayI., QuinnK., AllisonM.. Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-controlled, randomized study.Nephrol Dial Transplant1997; 12: 2593–6.
43.
KellumJ.A.. The use of diuretics and dopamine in acute renal failure: a systematic review of the evidence.Crit Care1997; 1: 53–9.
44.
LassniggA., DonnerE., GrubhoferG., PresterlE., DrumlW., Hiesmayr. Lack of renoprotective effects of dopamine and furosemide during cardiac surgery.J Am Soc Nephrol2000; 11: 97–104.
45.
VenkataramR., KellumJ.A.. The role of diuretic agents in the management of acute renal failure.Contrib Nephrol2001; 158–70.
46.
MehtaR.L., PascualM.T., SorokoS., ChertowG.M.for the PICARD Study Group. Diuretics, mortality, and nonrecovery of renal function in acute renal failure.JAMA2002; 288: 2547–53.
47.
CarcoanaO.V., MathewJ.P., DavisE., ByrneD.W., HayslettJ.P., HinesR.L., GarwoodS.. Mannitol and dopamine in patients undergoing cardiopulmonary bypass: A randomized clinical trial.Anesth Analg2003; 97: 1222–9.
48.
UchinoS., DoigG.S., BellomoR., MorimatsuH., MorgeraS., SchetzM., TanI., BoumanC., NacedoE., GibneyN., TolwaniA., RoncoC., KellumJ.A.. Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T. Kidney Investigators).Crit Care Med2004; 32: 1669–77.
49.
HoK.M., SheridanD.J.. Meta-analysis of furosemide to prevent or treat acute renal failure.BMJ2006; 333: 406–7.
50.
BagshawS.M., DelaneyA., HaaseM., GhaliW.A., BellomoR.. Loop diuretics in the management of acute renal failure: A systematic review and meta-analysis.Crit Care Resusc2007; 9: 60–8.
51.
CoteG., DenaultA., BelisleS.. N-acetylcysteine in the preservation of renal function in patients undergoing cardiac surgery.ASA Annual Meeting Abstracts2003; Abstract 420.
52.
HaaseM., Haase-FielitzA., BagshawS., ReadeM., MorgeraS., SeevenayagamS., MatalanisG., BuxtonB., DoolanL., BellomoR.. Phase II, randomized, controlled trial of high-dose N-acetylcyteine in high-risk cardiac surgery patients.Crit Care Med2007; 35: 1324–31.
53.
BoldtJ., BroschC., PiperS.N., SuttnerS., LehmannA., WerlingC.. Influence of prophylactic use of pentoxifylline on post-operative renal function impairment during cardiac surgery with cardiopulmonary bypass.Crit Car Med2001; 29: 952–8.
54.
LoefB.G., HenningR.H., EpemaA.H., RietmanG.W., van OeveranW., NavisG.J., EbelsT.. Effect of dexamethasone on perioperative renal function impairment during cardiac surgery with cardiopulmonary bypass.Br J Anaesth2004; 93: 793–8.
55.
MylesP.S., HuntJ.O., HoldgaardH.O., McRaeR., BucklandM.R., MoloneyJ., HallJ., BujorM.A., EsmoreD.S., DavisB.B., MorganD.J.. Clonidine and cardiac surgery: Haemodynamic and metablic effects, myocardial ischaemia and recovery.Anaesth Intensive Care1999; 27: 137–47.
56.
BergmanA.S., Odar-CederlofI., WestmanL., BjellerupP., HoglundP., OhqvistG.. Diltiazem infusion for renal protection in cardiac surgical patients with preexisting renal dysfunction.J Cadiothorac Vasc Anesth2002; 16: 294–9.
SharplesE.J., PatelN., BrownP., StewartK., Mota-PhilipeH., SheaffM., KieswichJ., AllenD., HarwoodS., RafteryM., ThiemermannC., YaqoobM.M.. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion.J Am Soc Nephrol2004; 15: 2115–24.
62.
ParetG., CohenA.J., BohnD.J.. Continuous arteriovenous hemofiltration after cardiac operations in infants and children.J Thorac Cardiovasc Surg1992; 104: 1225–30.
ElahiM.M., LinM.Y., JosephR.N., DhannapuniRR, SpytT.J.. Early hemofiltration improves survival in post-cardiotomy patients with acute renal failure.Eur J Cardiothorac Surg2004; 26: 1027–31.
68.
BapatV., Sabetai, RoxburghJ., YoungC., VennG.. Early and intensive continuous venovenous hemofiltration for acute renal failure after cardiac surgery.Interact Cardiovasc Thorac Surg2004; 3: 426–30.
69.
DemirkilicU., KuralayE., YenicesuM., CaglarK., OzB., CingozF., GunayC., YildirimV., CelyanS., ArslanM., VuralA., TatarH.. Timing of replacement therapy for acute renal failure after cardiac surgery.J Card Surg2004; 19: 17–20.
70.
EhrlichM., GarlickiM., SwistowskiJ., LabusK., GotebiewskiS., RydezewskiA.. Results after haemofiltration for acute renal failure after cardiac surgery.Kariochirurgia Torakochirugria Polska2006; 3: 323–5.
71.
MehtaR.L., KellumJ.A., ShahS.V., MolitorisB.A., RoncoC., WarnockD.G., LevinA.; the Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.Crit Care2007 Mar 1; 11: R31.
72.
Van den BergheG., WoutersP., WeekersF.. Intensive insulin therapy in the critically ill patients.N Engl J Med2001; 345: 1359–67.
73.
Rondon-BerriosH., PalevskyP.. Treatment of acute kidney injury: an update on the management of renal replacement therapy.Curr Opin Nephrol Hypertens2007; 16: 64–70.
74.
PalevskyP.. Clinical review: Timing and dose of continuous renal replacement therapy in acute kidney injury.Crit Care2007; 11: 232.
75.
D'IntiniV., RoncoC., BonelloM., BellomoR.. Renal replacement therapy in acute renal failure.Best Pract Res Clin Anaesthesiol2004; 18: 145–57.
